Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Nicardipine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 14 USDMF, 1 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 50 FDA Orange Book, 14 Europe, 1 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 CD Formulation, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 3 Kerry, 1 Keval Exports, 3 Lonza Capsugel, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 27 Coating Systems & Additives, 17 Thickeners and Stabilizers, 16 Direct Compression, 15 Taste Masking, 13 Controlled & Modified Release, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 11 Co-Processed Excipients, 11 Granulation, 9 Chewable & Orodispersible Aids, 9 Parenteral, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Solubilizers, 4 Emulsifying Agents, 4 Topical, 3 Coloring Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

19 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	Apothecon Pharmaceuticals	India	Agerson Bio Co., Ltd.	20230404-210-J-1467	Nicardipine hydrochloride	2023-04-04	Apothecon Pharmaceuticals Pvt. Ltd.	India	PLOT NO 1134, 1135, 1136, 1137, 1143B, 1144 A&B, 1138 A&B, Padra Jambusar Highway, Tal-Padra, Village-Dabhasa, City. Dabhasa-391 440, Dist. Vadodara, Gujarat State, India
31/10/2025	Lusochimica	Italy	Samoh Pharmaceutical Co., Ltd.	20230809-210-J-1488	Nicardipine hydrochloride	2023-08-09	Lusochimica SpA	Italy	Via Giotto 9, 23871 Lomagna (LC), Italy

Nicardipine Hydrochloride

Nicardipine Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

14 USDMF

1 CEP/COS

1 JDMF

2 EU WC

2 KDMF

7 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers

50 FDA Orange Book

14 Europe

1 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik

1 Rochem International Inc

6 SPI Pharma

8 DKSH

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

2 Kirsch Pharma

4 ACG Worldwide

2 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

1 CD Formulation

3 Corel Pharma Chem

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

5 Ideal Cures

2 Ingredion Pharma Solutions

3 Kerry

1 Keval Exports

3 Lonza Capsugel

7 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

28 Roquette

2 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

2 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders

27 Coating Systems & Additives

17 Thickeners and Stabilizers

16 Direct Compression

15 Taste Masking

13 Controlled & Modified Release

13 Film Formers & Plasticizers

12 Lubricants & Glidants

11 Co-Processed Excipients

11 Granulation

9 Chewable & Orodispersible Aids

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons